These data support the idea that CHCHD2 T61I point mutation may lead to transcriptomic changes similar to those observed in sporadic PD, again supporting the possibility of shared pathophysiologic mechanisms between CHCHD2 T61I and sporadic PD. This evidence concerns the gene CHCHD2 and Parkinson disease.